The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
Ivan Tancevski, Egon Demetz, Philipp Eller et al. · 2010
Read The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice by Ivan Tancevski, Egon Demetz, Philipp Eller et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008722.txt.
Description
Ivan Tancevski, Egon Demetz, Philipp Eller, and colleagues tested a thyroid-like drug aimed only at the liver. Their mouse study appeared in PLOS ONE in 2010. The compound, T-0681, mimics thyroid hormone in liver tissue. Such drugs can raise receptors that pull cholesterol from the blood. A liver-only action might spare the heart from thyroid side effects.
The team measured reverse cholesterol transport, the path that carries cholesterol out for disposal. They also watched artery plaque build-up in treated mice. Better transport paired with slower plaque growth would support the approach. The study weighs promise against the risks of thyroid mimicry.
Catalog record
| CREATOR | Ivan Tancevski, Egon Demetz, Philipp Eller et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008722